Switzerland and its long-standing sector cluster in life sciences provide fertile ground for biotech companies. The financial industry has been involved in the cluster almost since its inception and therefore has a long tradition in financing the sector. As a result of this conducive environment, the Swiss life sciences industry not only generates its own success stories in the field of biotech and drug development but is also attracting companies from abroad. This is also reflected on the SWX Swiss Exchange which represents the financial center very well. In 2006 two out of three biotech IPOs were cross-border listings. Read in this section what the finance place Switzerland can offer.